Hla class i and ii binding peptides and their uses
CA 2425648 A1 · Owner: Sette, Alessandro · Inventors: Southwood, Scott; Sidney, John; Sette, Alessandro
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides the means and methods for selecting immunogenic peptides and the immunogenic peptide compositions capable of specifically binding, glycoproteins encoded by HLA alleles and inducing T cell activation in T cells restricted, by the allele. The peptides are useful to elicit an immune response against a desired, antigen.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 18, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 18, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 18, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.